Although the All Ordinaries index has carved out a strong gain in 2019, it is nothing in comparison to the gains that have been made by the three shares listed below.
As of yesterday's close, all three shares had more than tripled in value since the start of the year. Here's why:
The AVITA Medical Ltd (ASX: AVH) share price has been the best performer on the All Ordinaries in 2019 with a stunning gain of 388%. Investors have been buying the global regenerative medicine company's shares due to the strong potential of its RECELL System. This system is a regeneration platform which was approved by the U.S. FDA late last year as a Class III device for the treatment of acute thermal burns. Investors appear confident the company will generate significant revenue in a U.S. market that management estimates to be worth US$5.7 billion per year currently.
The Bubs Australia Ltd (ASX: BUB) share price has rocketed a massive 222% higher since the turn of the year. A good portion of these gains have come in the last few weeks after the goat milk infant formula company announced an agreement with Chemist Warehouse and its expansion into cow milk infant formula. The latter is being seen as a great move by the company due to the size of the cow milk formula market in comparison to the goat milk formula market. According to its release, cow milk formula represents 95% of the Australian formula market. Bubs has its eyes on the premium side of the market and will offer an organic grass-fed range.
The Zip Co Ltd (ASX: Z1P) share price isn't far behind with a gain of 203% in 2019. Investors have been fighting to get hold of the payments company's shares since the release of a strong quarterly update last month. In the third quarter Zip Co reported a 20% increase in quarterly revenue to a record $23 million. In addition to this, it revealed that it added another 143,000 customers to its platform during the quarter, taking its total to a sizeable 1.2 million. Thanks to the addition of a number of key retailers and the growing popularity of buy now, pay later platforms, further strong growth is expected in the coming quarters.
